Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pravastatin vs placebo to prevent severe subcutaneous breast fibrosis in hyper-radiosensitive breast cancer patients
2019-002971-32Phase 3Completed
- Sponsor
- Institut du Cancer de Montpellier
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in breast cancer and Breast fibrosis comparing Pravastatin with Placebo (2 arms). Primary endpoint: breast fibrosis-free survival. Started Jun 2020; status: completed.
02
Drugs
pravastatin
03
Conditions
breast cancerBreast fibrosis
Beyond the preview
Go deeper on 2019-002971-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-002971-32.